Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

17.30
+0.15000.87%
Post-market: 17.300.00000.00%19:48 EDT
Volume:234.32K
Turnover:4.06M
Market Cap:6.17B
PE:-35.94
High:17.47
Open:17.21
Low:17.19
Close:17.15
52wk High:18.92
52wk Low:13.77
Shares:356.38M
Float Shares:45.50M
Volume Ratio:0.66
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4814
EPS(LYR):-1.0200
ROE:-2.52%
ROA:1.83%
PB:0.97
PE(LYR):-16.96

Loading ...

Bausch + Lomb's Dry Eye Disease Prescription Momentum Builds, Forex Turns as Modest Headwind in Q3, RBC Says

MT Newswires Live
·
Oct 08

Barclays Initiates Coverage on Bausch + Lomb With Overweight Rating, $24 Price Target

MT Newswires Live
·
Oct 07

Canada Research Roundup-First Quantum Minerals, Maple Leaf Foods, Pembina Pipeline

Reuters
·
Oct 07

Bausch + Lomb Advances Oral Dry AMD Treatment Development

MT Newswires Live
·
Oct 07

Bausch + Lomb advances oral treatment for dry AMD after FDA meeting

TIPRANKS
·
Oct 07

Bausch + Lomb to Present New AAO Data on enVista Aspire, IC-8 Apthera IOLs and Dry Eye Drugs Xiidra, Miebo

Reuters
·
Oct 06

Bausch + Lomb to Host Third-Quarter Results Call and Webcast

Reuters
·
Oct 05

SpyGlass Pharma Buys Santen Unit Advanced Vision Science for About $13 Million Cash

Reuters
·
Oct 01

Bausch + Lomb Presents Phase 4 MIEBO Contact Lens Wear Study at Academy 2026 Anaheim

Reuters
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO) and Longeveron (LGVN)

TIPRANKS
·
Sep 21

US FDA Sent Warning Letter to Bausch & Lomb on September 4

Reuters
·
Sep 15

Bausch + Lomb Wins EU CE Mark for SeeLyra Femtosecond Laser

Reuters
·
Sep 11

Bausch + Lomb initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Bausch + Lomb Unveils New ESCRS Clinical Data on enVista Aspire, LuxLife IOLs, ELIOS Glaucoma Procedure

Reuters
·
Sep 03

Bausch + Lomb publishes new research on en Vista Aspire IOLs

TIPRANKS
·
Sep 02

Bausch + Lomb Study Finds enVista Aspire IOLs Deliver Strong Distance, Intermediate Vision in Real-World Use

Reuters
·
Sep 02

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Reuters
·
Aug 25

Bausch + Lomb Advances Dual-Action Dry Eye Drop into Phase 3 After Phase 2 Day 15 Endpoint Win

Reuters
·
Aug 25

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17